SCHEMBL4063575

SCHEMBL4063575

CC(C)[C@H](CO)Nc1nc(Nc2ccc(S(=O)(=O)NCC3CCCO3)cc2)ncc1Br

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TNK2 Q07912 7/20 0.55
▸ CDK2 P24941 9/20 0.52
▸ CDK1 P06493 9/20 0.52
▸ KDR P35968 8/20 0.52
▸ CA2 P00918 2/20 0.52
▸ CDK4 P11802 2/20 0.52
▸ CDK7 P50613 2/20 0.52
▸ CDK9 P50750 2/20 0.52
▸ CCNT1 O60563 1/20 0.52
▸ CCND1 P24385 1/20 0.52
▸ CCNH P51946 1/20 0.52
▸ CCNB1 P14635 1/20 0.51
▸ CCNE1 P24864 1/20 0.51
▸ CCNA2 P20248 1/20 0.51
▸ CCNA1 P78396 1/20 0.51
▸ POLB P06746 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13648667 1.00 TNK2 (0.55) TNK2CDK2CDK1KDRCA2
SCHEMBL4060322 0.88 CDK1 (0.58) CDK2CDK1KDRCA2CDK4
SCHEMBL4060801 0.82 CDK1 (0.62) CDK2CDK1KDRCA2CDK4
SCHEMBL4058450 0.82 CDK1 (0.51) CDK2CDK1KDRCA2CDK4
SCHEMBL4063631 0.81 CDK1 (0.65) CDK2CDK1KDRCA2CDK4
SCHEMBL4062664 0.81 CDK1 (0.65) CDK2CDK1KDRCA2CDK4
SCHEMBL4064827 0.81 CDK1 (0.65) CDK2CDK1KDRCA2CDK4
SCHEMBL4063706 0.81 CDK1 (0.60) CDK2CDK1KDRCA2CDK4
SCHEMBL13648672 0.81 CDK1 (0.60) CDK2CDK1KDRCA2CDK4
SCHEMBL4058222 0.79 CDK1 (0.63) CDK2CDK1KDRCA2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 — — EP claimed
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 — — EP disclosed
Send feedback